GO:0072584 caveolin-mediated endocytosis: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072584 caveolin-mediated endocytosis is a biological process in which material is taken up into plasma membrane caveolae, which then pinch off to form endocytic caveolar carriers.
• Caveolae are small invaginations of the plasma membrane enriched in caveolin proteins, cholesterol, and sphingolipids, and they function in endocytosis, signaling, and mechanotransduction.
• This pathway is exploited by multiple bacterial pathogens and viruses, including HIV, to enter host cells and traffic within tissues [1,4].
• Caveolin-mediated endocytosis is involved in diverse physiological and pathological processes, including albumin handling in the glomerulus and extracellular vesicle uptake [3,7].
• Engineered caveolin-mediated endocytosis in yeast provides a tractable system to study the pathway and its components.
• The pathway can be targeted for drug delivery and gene therapy using nanoparticles modified to enter cells via caveolae.
Description
Caveolin-mediated endocytosis (GO:0072584) is a specialized endocytic route that begins when cargo is taken up into plasma membrane caveolae, which then pinch off to form endocytic caveolar carriers. Unlike clathrin-mediated endocytosis, this pathway is characterized by the involvement of caveolin proteins, a family of integral membrane proteins that shape caveolae and regulate their function. Caveolae are abundant in endothelial cells, adipocytes, fibroblasts, and muscle cells, where they participate in signal transduction, lipid homeostasis, and mechanoprotection. The pathway is also a portal of entry for certain pathogens and a route for cellular uptake of extracellular vesicles and nanoparticles [1,3,8]. For researchers, caveolin-mediated endocytosis is important because it intersects with cell biology, infectious disease, cancer, and drug delivery [1,4,5,8]. For example, HIV can exploit caveolin-mediated endocytosis to cross the colonic barrier, and bacterial pathogens have evolved mechanisms to hijack caveolae for invasion [1,4]. In glomerular disease, albumin endocytosis is caveolin-mediated, highlighting its role in kidney physiology. Moreover, engineering caveolin-mediated endocytosis in Saccharomyces cerevisiae has provided a powerful model to dissect the molecular machinery of this pathway. Understanding the molecular players and regulatory mechanisms of caveolin-mediated endocytosis is essential for developing targeted therapies and for interpreting experimental data from endocytosis studies [1,2,8]. This article summarizes the current knowledge based on authoritative QuickGO annotation and peer-reviewed literature, and outlines how CRISPR-based models can be used to study this process.
caveolin-mediated endocytosis At A Glance
| GO ID | GO:0072584 |
|---|---|
| GO term | caveolin-mediated endocytosis |
| Ontology | biological_process |
| Synonym | caveolae-dependent endocytosis; caveolae-mediated endocytosis; caveolin-dependent endocytosis |
| Definition | An endocytosis process that begins when material is taken up into plasma membrane caveolae, which then pinch off to form endocytic caveolar carriers. |
| Major function | Uptake of extracellular material, including pathogens, extracellular vesicles, and nanoparticles, via caveolae. |
| Related cellular component | Caveolae, plasma membrane invaginations enriched in caveolin proteins, cholesterol, and sphingolipids. |
| Pathogen exploitation | Exploited by bacterial pathogens and viruses such as HIV for host cell entry and trafficking. |
| Experimental models | Saccharomyces cerevisiae engineered for caveolin-mediated endocytosis; mammalian cell lines; mouse models. |
What Is GO:0072584?
Caveolin-mediated endocytosis is an endocytosis process that begins when material is taken up into plasma membrane caveolae, which then pinch off to form endocytic caveolar carriers. This definition, based on the Gene Ontology (GO:0072584), distinguishes it from other endocytic pathways by its dependence on caveolae, which are cholesterol- and sphingolipid-rich membrane microdomains stabilized by caveolin proteins.
Why Is caveolin-mediated endocytosis Important in Cell Biology?
Caveolin-mediated endocytosis is a fundamental cellular process that regulates the uptake of nutrients, signaling molecules, and pathogens, and it is implicated in a wide range of human diseases, including infections, cancer, and kidney disorders [1,4,5,7]. Its unique dependence on caveolae makes it a distinct target for therapeutic intervention and a critical pathway to consider in drug delivery and nanomedicine.
• Provides a route for cellular entry of bacterial pathogens and viruses, including HIV, contributing to infectious disease pathogenesis [1,4].
• Mediates the uptake of extracellular vesicles, influencing intercellular communication.
• Plays a role in glomerular albumin endocytosis, with implications for kidney disease.
• Is exploited for targeted drug delivery using nanoparticles modified to enter via caveolae.
• Can be engineered in yeast to study the molecular basis of caveolin-mediated endocytosis.
• Involved in the trafficking of glypican-3-targeted exosomes for cancer cytotherapy.
• Serves as a potential therapeutic target for modulating pathogen entry and drug delivery [1,8].
• Contributes to cellular signaling and mechanotransduction through caveolae-associated proteins.
• Relevant to cancer biology, as caveolin-1 expression is altered in various tumors.
• Offers a model system for studying endocytic mechanisms and membrane dynamics.
What Happens During caveolin-mediated endocytosis?
Cargo binding and caveolae formation
In simple terms: The cell forms small pits called caveolae on its surface to capture material from outside.
Caveolin-mediated endocytosis begins with the formation of caveolae, which are flask-shaped invaginations of the plasma membrane enriched in caveolin-1, caveolin-2, and caveolin-3, along with cholesterol and sphingolipids. These domains serve as platforms for the concentration of specific cargo, including pathogens, extracellular vesicles, and nanoparticles [1,3,8]. The caveolin proteins are essential for the structural integrity of caveolae and for their ability to invaginate.
Caveolar invagination and scission
In simple terms: The pits pinch off from the membrane to form tiny bubbles inside the cell.
Once cargo is sequestered, caveolae undergo invagination and scission from the plasma membrane to form endocytic caveolar carriers. This process requires dynamin and other accessory proteins, although the exact molecular machinery may vary by cell type. The resulting carriers deliver their contents to the endosomal system, including caveosomes and the endoplasmic reticulum, for further processing.
Trafficking and cargo release
In simple terms: The bubbles travel inside the cell and release their contents where needed.
After scission, caveolar carriers are targeted to specific intracellular compartments, such as caveosomes, the Golgi apparatus, and the endoplasmic reticulum. This trafficking allows for the delivery of cargo to different destinations, including the nucleus and mitochondria, depending on the cell type and cargo. Pathogens like HIV can exploit this trafficking to reach sites of replication.
Pathogen exploitation
In simple terms: Some bacteria and viruses use these pits to break into cells.
Many bacterial pathogens and viruses have evolved to exploit caveolin-mediated endocytosis for host cell entry and dissemination. For example, HIV can utilize caveolin-mediated endocytosis to cross the colonic epithelial barrier, facilitating viral dissemination. Understanding these mechanisms is critical for developing strategies to block pathogen entry.
Role in extracellular vesicle uptake
In simple terms: Cells can also take in tiny packages released by other cells through these pits.
Caveolin-mediated endocytosis is one of the routes by which cells internalize extracellular vesicles, which are membrane-bound particles released by cells for intercellular communication. This uptake can influence processes such as immune modulation and cancer progression. The specific contribution of caveolin-mediated endocytosis to extracellular vesicle uptake depends on the vesicle surface composition and the recipient cell type.
Key Genes Involved in GO:0072584 caveolin-mediated endocytosis
The following genes and proteins are key players in caveolin-mediated endocytosis, based on their established roles in caveolae structure, cargo recognition, and membrane trafficking.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAV1 | Major structural component of caveolae; essential for caveolae formation and endocytosis | Knockout models show loss of caveolae and impaired caveolin-mediated endocytosis; implicated in cancer and cardiovascular disease |
| CAV2 | Co-expressed with CAV1; stabilizes caveolae and modulates endocytic function | Knockdown affects caveolae stability and endocytic trafficking |
| CAV3 | Muscle-specific caveolin; forms caveolae in muscle cells | Mutations cause limb-girdle muscular dystrophy and rippling muscle disease |
| CAVIN1 (PTRF) | Essential for caveolae formation and stability; binds caveolin | Mutations cause congenital generalized lipodystrophy type 4 and muscular dystrophy |
| CAVIN2 (SDPR) | Accessory protein involved in caveolae biogenesis | Regulates caveolae dynamics and endocytosis |
| CAVIN3 (SRBC) | Modulates caveolae formation and signaling | Implicated in cancer and metabolic regulation |
| DYN2 (DNM2) | Dynamin-2; mediates scission of caveolar carriers | Required for caveolin-mediated endocytosis; mutations cause centronuclear myopathy |
| ALB | Albumin; cargo for caveolin-mediated endocytosis in glomerular endothelial cells | Albumin endocytosis is caveolin-mediated; relevant to kidney disease |
| GPC3 | Glypican-3; cargo receptor for exosome uptake via caveolin-mediated endocytosis | Target for cancer therapy using glypican-3-targeted exosomes |
| CD4 | HIV receptor; facilitates HIV entry via caveolin-mediated endocytosis | HIV exploitation of caveolin-mediated endocytosis in colonic barrier |
| EGFR | Epidermal growth factor receptor; signaling modulated by caveolae | Caveolin-1 regulates EGFR signaling and endocytosis |
| TGFBR1 | TGF-beta receptor; localized in caveolae | Caveolae regulate TGF-beta signaling |
| SRC | Non-receptor tyrosine kinase; interacts with caveolin-1 | Caveolin-1 regulates Src activity in caveolae |
| NOS3 | Endothelial nitric oxide synthase; localized in caveolae | Caveolin-1 inhibits eNOS; regulates vascular tone |
| INSR | Insulin receptor; signaling modulated by caveolae | Caveolae regulate insulin signaling and glucose uptake |
| PLSCR1 | Phospholipid scramblase 1; involved in caveolae-mediated endocytosis | Modulates caveolin-dependent uptake of nanoparticles |
| CHKA | Choline kinase alpha; involved in phosphatidylcholine synthesis for caveolae | Affects caveolae formation and endocytosis |
| SCARB1 | Scavenger receptor class B member 1; localized in caveolae | Mediates selective cholesterol uptake via caveolin-mediated endocytosis |
How Is caveolin-mediated endocytosis Regulated?
Caveolin-mediated endocytosis is regulated at multiple levels, including the expression and post-translational modification of caveolin proteins, the availability of cholesterol and sphingolipids, and the activity of signaling pathways such as Src and protein kinase C. Caveolin-1 phosphorylation on tyrosine 14 modulates caveolae dynamics and endocytosis. Additionally, the pathway can be influenced by extracellular stimuli, including growth factors and mechanical stress, which alter caveolae stability and cargo uptake. Pathogens may also modulate the pathway to enhance their entry [1,4].
caveolin-mediated endocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CAV1 | Cancer, cardiovascular disease, pulmonary hypertension | CAV1 knockout mice; cancer cell lines with CAV1 overexpression or knockdown |
| CAV3 | Limb-girdle muscular dystrophy, rippling muscle disease | CAV3 knockout mice; patient-derived myoblasts |
| CAVIN1 | Congenital generalized lipodystrophy type 4, muscular dystrophy | CAVIN1 knockout mice; adipocyte differentiation models |
| ALB | Albuminuria, glomerular disease | Podocyte-specific knockout of caveolin-1; albumin uptake assays |
| GPC3 | Hepatocellular carcinoma, cancer therapy | Glypican-3-targeted exosome delivery in mouse tumor models |
Infectious diseases
Caveolin-mediated endocytosis is exploited by numerous pathogens, including bacteria and viruses, to enter host cells and disseminate. HIV, for instance, can utilize this pathway to cross the colonic epithelial barrier, contributing to viral transmission. Targeting caveolin-mediated endocytosis may offer a strategy to block pathogen entry.
Cancer
Caveolin-1, the main structural protein of caveolae, has been implicated in cancer progression, acting as a tumor suppressor or promoter depending on the context. Caveolin-mediated endocytosis is also involved in the uptake of glypican-3-targeted exosomes for cancer cytotherapy, highlighting its potential in drug delivery.
Kidney disease
Albumin endocytosis in the glomerulus is caveolin-mediated, and defects in this process can lead to albuminuria and kidney injury. This makes caveolin-mediated endocytosis a potential therapeutic target for glomerular diseases.
Muscular dystrophy and lipodystrophy
Mutations in caveolin-3 (CAV3) cause limb-girdle muscular dystrophy, and mutations in CAVIN1 (PTRF) cause congenital generalized lipodystrophy type 4, underscoring the importance of caveolae in muscle and adipose tissue.
From caveolin-mediated endocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CAV1 abolish caveolin-mediated endocytosis? | CAV1 knockout cell lines (e.g., HeLa, MEFs) and CAV1 knockout mice |
| How does a point mutation in CAV3 affect caveolae formation? | CRISPR knock-in of patient-specific CAV3 mutations in myoblasts |
| Can caveolin-mediated endocytosis be engineered in yeast? | Saccharomyces cerevisiae expressing mammalian caveolin-1 and caveolin-2 |
| What is the role of CAVIN1 in caveolae stability? | CAVIN1 knockout mice and knockdown cell lines |
| How does HIV exploit caveolin-mediated endocytosis? | Colonic epithelial cell lines and primary cells treated with caveolin inhibitors |
| Can nanoparticles be designed to enter cells via caveolin-mediated endocytosis? | Chondroitin sulfate-modified calcium phosphate nanoparticles in transfection assays |
How to Study the caveolin-mediated endocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Internalization and trafficking of fluorescent cargo | Visualizing caveolin-mediated endocytosis in live cells |
| Electron microscopy | Ultrastructure of caveolae and caveolar carriers | Confirming morphological features of caveolae |
| Co-immunoprecipitation | Protein-protein interactions with caveolin | Identifying components of the caveolar complex |
| Proteomics | Protein composition of caveolae-enriched fractions | Discovering novel regulators of caveolin-mediated endocytosis |
| CRISPR knockout | Loss-of-function effects on endocytosis | Testing the requirement of candidate genes |
| CRISPR knock-in | Effects of specific mutations on caveolae function | Modeling patient mutations in CAV3 or CAV1 |
| RNA interference | Gene knockdown effects on endocytosis | Transient silencing of caveolin genes |
| Nanoparticle uptake assays | Efficiency of caveolin-mediated delivery | Testing drug delivery systems |
Fluorescence microscopy and live-cell imaging
Fluorescence microscopy using fluorescently labeled cargo (e.g., albumin, nanoparticles, or pathogens) allows visualization of caveolin-mediated endocytosis in real time [1,8]. Co-localization with caveolin-1 or caveolin-2 confirms the involvement of caveolae. Live-cell imaging can track the internalization and trafficking of cargo.
Electron microscopy
Electron microscopy provides ultrastructural evidence of caveolae and caveolar carriers, confirming the morphological hallmarks of caveolin-mediated endocytosis. Immunogold labeling can localize caveolin proteins to these structures.
Biochemical assays and proteomics
Biochemical fractionation and co-immunoprecipitation can identify proteins associated with caveolae and caveolar carriers. Proteomic analysis of caveolae-enriched fractions reveals the composition and dynamics of the endocytic machinery.
Genetic manipulation and CRISPR screens
CRISPR knockout, knock-in, and overexpression models are used to dissect the function of genes involved in caveolin-mediated endocytosis [1,2]. Genome-wide CRISPR screens can identify novel regulators of this pathway.
How CRISPR Can Be Used to Study GO:0072584 caveolin-mediated endocytosis
Knockout
CRISPR knockout of CAV1, CAV2, CAV3, or CAVIN1 in cell lines and animal models abolishes caveolae formation and impairs caveolin-mediated endocytosis, providing definitive evidence for their essential roles. These models are used to study the contribution of the pathway to pathogen entry, signaling, and disease [1,4].
Point Mutation
CRISPR knock-in of disease-associated point mutations, such as those in CAV3 linked to muscular dystrophy, allows researchers to study the functional consequences on caveolae formation and endocytosis. Point mutations can also be introduced into cargo receptors to dissect binding specificity.
Knock-in
Knock-in of tagged caveolin proteins (e.g., GFP-CAV1) enables live-cell imaging and proteomic analysis of caveolae dynamics. Knock-in of reporter genes under the control of caveolin promoters can be used to monitor expression in vivo.
Overexpression
Overexpression of caveolin-1 or caveolin-2 in cells that normally lack caveolae, such as Saccharomyces cerevisiae, can reconstitute caveolin-mediated endocytosis and provide a simplified system to study the pathway. Overexpression in mammalian cells can enhance cargo uptake and is used in drug delivery studies.
How EDITGENE Supports caveolin-mediated endocytosis Research
Researchers studying caveolin-mediated endocytosis-related genes often need to determine whether a candidate gene is causally involved in the pathway, how specific mutations affect caveolae function, and whether modulating gene expression can alter cargo uptake. EDITGENE provides a comprehensive suite of CRISPR services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for caveolin-mediated endocytosis research.
Frequently Asked Questions About caveolin-mediated endocytosis
What is caveolin-mediated endocytosis?
Caveolin-mediated endocytosis (GO:0072584) is an endocytosis process that begins when material is taken up into plasma membrane caveolae, which then pinch off to form endocytic caveolar carriers.
What genes are involved in caveolin-mediated endocytosis?
Key genes include CAV1, CAV2, CAV3, CAVIN1, CAVIN2, CAVIN3, and DNM2, among others.
How does caveolin-mediated endocytosis differ from clathrin-mediated endocytosis?
Caveolin-mediated endocytosis relies on caveolae, which are cholesterol- and sphingolipid-rich membrane invaginations stabilized by caveolin proteins, whereas clathrin-mediated endocytosis uses clathrin-coated pits.
Which pathogens exploit caveolin-mediated endocytosis?
Bacterial pathogens and viruses, including HIV, can exploit caveolin-mediated endocytosis for host cell entry and dissemination [1,4].
What is the role of caveolin-1 in endocytosis?
Caveolin-1 is the major structural protein of caveolae and is essential for caveolae formation and caveolin-mediated endocytosis.
Can caveolin-mediated endocytosis be studied in yeast?
Yes, engineering Saccharomyces cerevisiae to express mammalian caveolin proteins reconstitutes caveolin-mediated endocytosis and provides a tractable model.
How is caveolin-mediated endocytosis used in drug delivery?
Nanoparticles modified with specific ligands, such as chondroitin sulfate, can be designed to enter cells via caveolin-mediated endocytosis for efficient transfection or drug delivery.
What diseases are associated with defects in caveolin-mediated endocytosis?
Defects are linked to muscular dystrophy, lipodystrophy, kidney disease, and cancer, among others [1,7].
What experimental methods are used to study caveolin-mediated endocytosis?
Common methods include fluorescence microscopy, electron microscopy, biochemical assays, proteomics, and CRISPR-based genetic manipulation [1,8].
How can CRISPR be used to study caveolin-mediated endocytosis?
CRISPR knockout, knock-in, point mutation, and overexpression models allow researchers to dissect the function of genes involved in the pathway and to model disease-associated mutations [1,2].
Conclusion
Caveolin-mediated endocytosis (GO:0072584) is a distinct endocytic pathway critical for cellular uptake of diverse cargo, including pathogens, extracellular vesicles, and nanoparticles [1,3,8]. Its involvement in infectious diseases, cancer, and kidney disorders underscores its biomedical importance [1,4,5,7]. Advances in CRISPR-based models and bioinformatics are accelerating our understanding of the molecular mechanisms and regulation of this pathway [1,2]. EDITGENE offers comprehensive services to support research on caveolin-mediated endocytosis, from gene knockout to library screening.
References
- 1. Barman D et al.. 2024. Caveolin-Mediated Endocytosis: Bacterial Pathogen Exploitation and Host-Pathogen Interaction.. Cells 14(1) PMID: 39791703
- 2. Zhang Q et al.. 2022. Engineering caveolin-mediated endocytosis in Saccharomyces cerevisiae.. Synth Syst Biotechnol 7(4):1056-1063 PMID: 35845314
- 3. Mulcahy LA et al.. 2014. Routes and mechanisms of extracellular vesicle uptake.. J Extracell Vesicles 3 PMID: 25143819
- 4. Anwar A et al.. 2022. Impact of Caveolin-Mediated Endocytosis on the Trafficking of HIV within the Colonic Barrier.. J Virol 96(7):e0020222 PMID: 35297667
- 5. Liu J et al.. 2024. Glypican-3-targeted macrophages delivering drug-loaded exosomes offer efficient cytotherapy in mouse models of solid tumours.. Nat Commun 15(1):8203 PMID: 39313508
- 7. Razzak M. 2014. Glomerular disease: Albumin endocytosis is caveolin-mediated.. Nat Rev Nephrol 10(5):242 PMID: 24642802
- 8. Zhang J et al.. 2023. Chondroitin sulfate modified calcium phosphate nanoparticles for efficient transfection via caveolin-mediated endocytosis.. Int J Biol Macromol 253(Pt 4):127046 PMID: 37742889
